Frontlight ResearchEarly access
Trial site
Karmanos Cancer Institute Weisberg Cancer Treatment Center
- 5running trials
- 2closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Head and neck cancer3 trials
- Lung cancer3 trials
- Acute myeloid leukaemia2 trials
- Colorectal cancer2 trials
- Diffuse large B-cell lymphoma2 trials
- Pancreatic cancer2 trials
- Bladder cancer1 trial
- Endometrial cancer1 trial
- Multiple myeloma1 trial
- Myelodysplastic syndromes1 trial
- Ovarian cancer1 trial
- Phase
- Phase 13 trials
- Phase 23 trials
- Phase 31 trial
- Status
- Active, not recruiting4 trials
- Terminated2 trials
- Recruiting1 trial
- Lead sponsor
- Seagen, a wholly owned subsidiary of Pfizer6 trials
- Pfizer1 trial
Running trials
Active, not recruiting
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Active, not recruiting
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
Active, not recruiting
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Active, not recruiting
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
Closed trials
Terminated
Terminated
Site data: ClinicalTrials.govUpdated 12 Nov 2026